Join to View Full Profile
1 Hoag DriveBuilding 41Newport Beach, CA 92663
Phone+1 949-764-4060
Dr. Benjamin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (Irvine)Fellowship, Hematology and Medical Oncology, 2019 - 2022
University of California Davis HealthResidency, Internal Medicine, 2016 - 2019
Tulane University School of MedicineClass of 2016
Certifications & Licensure
CA State Medical License 2017 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Genitourinary Cancers Symposium Merit Award Conquer Cancer, the ASCO Foundation, 2022
- Outstanding Fellow/Resident Research Award – Clinical/Translational Research UCI School of Medicine, 2022
Clinical Trials
- A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer Start of enrollment: 2025 Jan 23
- Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01) Start of enrollment: 2022 Sep 15
- Study of IDE397 in Participants With Solid Tumors Harboring MTAP Deletion Start of enrollment: 2021 Apr 14
Publications & Presentations
PubMed
- Understanding Patient and Oncologist Preferences in the Management of Metastatic Renal Cell Carcinoma.Omid Yazdanpanah, Aditya Mahadevan, David J Benjamin, Elham Vosoughi, Ali Raad
Cancer Treatment and Research Communications. 2025-12-09 - A decade review of mental health monitoring in clinical trials for United States Food and Drug Administration-approved genitourinary cancer treatments.Farzad Teymouri, Parnian Jabbari, Omid Yazdanpanah, Aditya Mahadevan, Arash Rezazadeh Kalebasty
BJU International. 2025-10-01 - Guiding first-line treatment decisions in advanced urothelial carcinoma: a global survey.Enrique Grande, Joaquim Bellmunt, Syed A Hussain, Mubarak M Al Mansour, Aristotle Bamias
The Oncologist. 2025-10-01
Abstracts/Posters
- Ivermectin in Cancer, 2025: Internet Trends, Scientific Data, Ongoing Trials, and News CoverageDavid J. Benjamin, Arash Rezazadeh, ESMO Congress 2025, Berlin, Germany, 10/19/2025
- State of the genitourinary medical oncology workforce in the United States, 2024David Joseph Benjamin, Arash Rezazadeh, ASCO Genitourinary Cancers Symposium, San Francisco, CA, 2/15/2025
- Characterization of genitourinary drug approvals by the FDA, 2020-2024David Joseph Benjamin, Arash Rezazadeh, ASCO Genitourinary Cancers Symposium, San Francisco, CA, 2/14/2025
Lectures
- The Global Medical Oncology Workforce, 2025: Disparities in Access to CareESMO Congress 2025, Berlin, Germany - 10/18/2025
- Navigating la/mUC Treatment Options: Right Treatment for the Right PatientAVENUES Medical Meeting, Lisbon, Portugal - 5/10/2025
- Retrospective Analysis of Treatment Initiation and Treatment Delay in Metastatic Renal Cell CarcinomaDAVA Oncology 7th Annual Summit on Genitourinary Malignancies. Colorado Springs, CO - 11/24/2024
Authored Content
- I Watched 100 Movies About Cancer. Here's What They Get WrongMay 2024
Press Mentions
Metformin: Science Finds New Benefits from an Old DrugAugust 25th, 2025
Metformin: Science finds new benefits from an old drugAugust 25th, 2025
Real-World Data Help Fill the Gaps Left by Clinical Trial Results in Urothelial CarcinomaJune 9th, 2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
